Herbal Medicine Extracts RM01 for Alzheimer's Treatment
Summary
The USPTO has published patent application US20260097090A1, filed September 26, 2023, and published April 9, 2026, covering herbal extract compositions for treating neurodegenerative diseases including Alzheimer's disease. The composition includes extracts from Ophiopogon japonicus, Barbary Wolfberry, Rhizoma Acori tatarinowii, and Codonopsis pilosula. This is a patent application publication, not a granted patent, and does not confer any regulatory approval for the claimed treatments.
What changed
The USPTO published patent application US20260097090A1 on April 9, 2026, covering methods of treating neurodegenerative diseases such as Alzheimer's using herbal extract compositions. The compositions include extracts from a mixture of four botanical ingredients: Ophiopogon japonicus, Barbary Wolfberry, Rhizoma Acori tatarinowii, and Codonopsis pilosula. The application claims methods of treatment, compositions, and methods of preparation.
Affected parties in the pharmaceutical and nutraceutical sectors should monitor this application as it may affect freedom-to-operate for herbal Alzheimer's treatment products. The patent application does not create compliance obligations or regulatory requirements. The application remains pending and may be granted, rejected, or modified in the examination process.
What to do next
- Monitor for patent grant or rejection
Archived snapshot
Apr 12, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
HERBAL MEDICINE EXTRACTS RM01 AND USES AND METHODS OF PREPARATION THEREOF
Application US20260097090A1 Kind: A1 Apr 09, 2026
Inventors
Hong YE, Chengbao YE
Abstract
The present application provides methods of treating a neurodegenerative disease (such as Alzheimer's disease) in patients by use of a herbal extract composition that has an extract from a mixture including Ophiopogon japonicus, Barbary Wolfberry, Rhizoma Acori tatarinowii and Codonopsis pilosula. Compositions having such extract and the methods of preparing such a composition are also contemplated.
CPC Classifications
A61K 36/8968 A61K 36/344 A61K 36/815 A61K 36/882 A61P 25/28
Filing Date
2023-09-26
Application No.
19115183
Related changes
Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.